Most Recent

image: FDA Considers Three-Parent IVF

FDA Considers Three-Parent IVF

By | October 17, 2013

The US regulatory agency will meet next week to discuss whether to allow human trials of a technique that combines the genetic information of three adults.

0 Comments

image: Week in Review: October 7–11

Week in Review: October 7–11

By | October 11, 2013

Nobels awarded for vesicle trafficking and computational chemistry; building 3-D microbial communities; mislabeled microbes cause retractions

0 Comments

image: Fighting Viruses with RNAi

Fighting Viruses with RNAi

By | October 10, 2013

The long-debated issue of whether mammals can use RNA interference as an antiviral defense mechanism is finally put to rest.

0 Comments

image: Mislabeled Microbes Cause Two Retractions

Mislabeled Microbes Cause Two Retractions

By | October 10, 2013

Two papers on plant immunity have been retracted, and questions remain about others with similar results. 

9 Comments

image: Behavior Brief

Behavior Brief

By | October 8, 2013

A round-up of recent discoveries in behavior research

0 Comments

image: Building 3-D Microbial Communities

Building 3-D Microbial Communities

By | October 7, 2013

Researchers apply a 3-D printing technique to structure populations of bacteria in a three-dimensional environment.

0 Comments

image: Trouble in the Heartland

Trouble in the Heartland

By | October 1, 2013

A new tick-borne disease has emerged in the US Midwest—and the culprit is not a bacterium. 

0 Comments

image: Behavior Brief

Behavior Brief

By | September 27, 2013

A round-up of recent discoveries in behavior research

0 Comments

image: Week in Review: September 23–27

Week in Review: September 23–27

By | September 27, 2013

Antibiotic cycling makes a comeback in the lab; how life scientists can learn from astronauts; napping to conquer fears; deconstructing the cancer R&D crisis

0 Comments

image: Giving Antibiotic Cycling Another Shot

Giving Antibiotic Cycling Another Shot

By | September 25, 2013

Switching up the drugs used to treat bacterial infections could help clinicians battle both illness and resistance at the same time.

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech